Researchers from The Hebrew University of Jerusalem and Penn State College of Medicine have made an important discovery about the protein alpha-synuclein, associated with the development of Parkinson’s and dementia. It gives hope for new therapeutics to delay or halt their progression.
https://www.cell.com/structure/fulltext/S0969-2126(21)00160-X